SS Innovations International Inc. (NASDAQ: SSII) has been named the winner of the Outstanding Company category at the 2026 Surgical Robotics Industry Awards, an independent recognition that underscores the company's growing presence in the competitive surgical robotics market. The award was presented after SS Innovations was selected from a field of ten finalists that included well-established medical technology companies such as Intuitive, Johnson & Johnson MedTech, and Medtronic, according to the company's announcement (https://nnw.fm/mXdgs).
The Surgical Robotics Industry Awards evaluate companies based on commercial performance, technological innovation, societal impact, customer recognition, ethical standards, and workplace practices. The recognition comes as SS Innovations continues to expand the global footprint of its SSi Mantra surgical robotic platform. As of June 22, 2026, surgeons had completed 11,719 cumulative multi-specialty procedures using the system, including 612 cardiac surgeries, 175 telesurgeries, and 212 pediatric operations. The platform has been used in more than 170 different surgical procedures, demonstrating versatility across multiple disciplines.
Training has also scaled alongside system adoption, with approximately 2,100 physicians completing training on the SSi Mantra platform. This is a critical factor for hospital purchasing decisions and long-term utilization of robotic surgery systems. The company's commercial reach has broadened internationally, with regulatory approvals granted in 14 countries: Colombia, Ecuador, Guatemala, Guyana, India, Indonesia, Iraq, Kenya, Nepal, Oman, the Philippines, Sri Lanka, Ukraine, and the United Arab Emirates. These approvals support continued market expansion as healthcare systems evaluate robotic-assisted surgery.
Chairman and Chief Executive Officer Dr. Sudhir Srivastava stated that the award reflects the company's focus on expanding access to robotic surgery while developing technologies to improve affordability for hospitals and healthcare systems. The SSi Mantra is a modular, multi-arm robotic surgery platform featuring between three and five robotic arms, a 3D 4K visualization system, an ergonomic surgeon console, and digital imaging capabilities. Its instrument portfolio includes more than 40 robotic instruments, including 5-millimeter instruments for pediatric and ear, nose, and throat procedures. The company has also developed the SSi MantrAsana, a portable tele-surgeon console that supports remote surgical capabilities, with over 20 cardiac telesurgeries performed to date.
For investors, the award provides an independent industry endorsement as the company competes in the rapidly growing global surgical robotics market. More information is available on the company's website at www.SSInnovations.com.
